Insider Selling: Envista (NYSE:NVST) SVP Sells $220,000.00 in Stock

Envista Holdings Corporation (NYSE:NVST) SVP Mischa Reis sold 8,000 shares of the company’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total transaction of $220,000.00. Following the completion of the transaction, the senior vice president owned 27,321 shares of the company’s stock, valued at $751,327.50. This trade represents a 22.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Envista Trading Up 0.5%

Shares of NYSE:NVST traded up $0.14 on Monday, hitting $27.34. The company had a trading volume of 1,793,803 shares, compared to its average volume of 2,951,562. The firm’s 50-day simple moving average is $26.90 and its two-hundred day simple moving average is $26.30. The firm has a market capitalization of $4.39 billion, a price-to-earnings ratio of 47.15, a P/E/G ratio of 1.30 and a beta of 0.86. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47. Envista Holdings Corporation has a 1 year low of $18.77 and a 1 year high of $30.42.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The company had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. During the same quarter in the previous year, the company earned $0.26 earnings per share. Envista’s quarterly revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Equities analysts anticipate that Envista Holdings Corporation will post 1.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently issued reports on NVST. Zacks Research raised Envista from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 7th. Robert W. Baird set a $34.00 price target on Envista in a research note on Thursday, August 6th. Mizuho set a $29.00 price objective on Envista in a report on Thursday, August 6th. BMO Capital Markets initiated coverage on Envista in a research report on Wednesday, July 8th. They set a “market perform” rating and a $27.00 price objective for the company. Finally, Barclays dropped their target price on shares of Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, June 11th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $29.31.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Envista during the second quarter valued at $25,000. Caitong International Asset Management Co. Ltd boosted its stake in Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after purchasing an additional 1,504 shares in the last quarter. Allworth Financial LP boosted its stake in Envista by 75.4% in the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after purchasing an additional 776 shares in the last quarter. Nykredit A S purchased a new stake in Envista during the 2nd quarter valued at about $52,000. Finally, UMB Bank n.a. grew its position in Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after purchasing an additional 636 shares during the last quarter.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.